Rheumatoid arthritis: An autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: Role of cardiovascular magnetic resonance

Inflammation and Allergy - Drug Targets

Volumn 13, Issue 2, 2014, Pages 81-93

  Mavrogeni, Sophie ^a   Dimitroulas, Theodoros ^b   Bucciarelli Ducci, Chiara ^c   Ardoin, Stacy ^d   Sfikakis, Petros P ^e   Kolovou, Genovefa ^a   Kitas, George D ^f  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Amyloidosis; Cardiac magnetic resonance; Coronary artery disease; Diabetes mellitus; Myocarditis; Rheumatoid arthritis; Vasculitis

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; HOMOCYSTEINE; TUMOR NECROSIS FACTOR INHIBITOR;

ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; COST; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIFFUSE SUBENDOCARDIAL VASCULITIS; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; HEART AMYLOIDOSIS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; MICROANGIOPATHY; MYOCARDITIS; PATHOPHYSIOLOGY; PERICARDITIS; PREDICTIVE VALUE; RELIABILITY; REPRODUCIBILITY; RHEUMATOID ARTHRITIS; VALVULAR HEART DISEASE; VASCULITIS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CARDIOVASCULAR DISEASES; FEMALE; IMMUNOLOGY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; CARDIOMYOPATHY; COST EFFECTIVENESS ANALYSIS; FIBROSIS; HEART EDEMA; PERIPHERAL OCCLUSIVE ARTERY DISEASE;

ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84903718052     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871528113666140131151522     Document Type: Article

References (123)

1. Goodson, N.; Marks, J.; Lunt, M.; Symmons, D. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s. Ann. Rheum. Dis., 2005, 64(11), 1595-1601.
2. Avina-Zubieta, J.; Choi, H.; Sadatsafavi, M.; Etminan, M.; Esdaile, J.; Lacaille, D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum., 2008, 59, 1690-1697.
3. Khan, E.A.; Stamp, L.K.; O'Donnell, J.L.; Chapman, P.T. Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999-2008. Int. J. Rheum. Dis., 2013, 16(1), 19-23.
4. Kvalvik, A.G.; Jones, M.A.; Symmons DPM. Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992. Scand. J. Rheumatol., 2000, 29, 29-37.
5. Van Doornum, S.; McColl, G.; Wicks, I.P. Accelerated atherosclerosis. An extraarticular feature of rheumatoid arthritis? Arthritis Rheum., 2002, 4, 862-873.
6. Nurmohamed, M.T. Cardiovascular risk in rheumatoid arthritis. Autoimmun. Rev., 2009, 8(8), 663-667.
7. Chung, C.; Giles, J.; Petri, M.; Szklo, M.; Post, W.; Blumenthal, R.S.; Gelber, A.C.; Ouyang, P.; Jenny, N.S.; Bathon, J.M. Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin. Arthritis Rheum., 2012, 41, 535-544.
8. John, H.; Kitas, G.; Toms, T.; Goodson, N. Cardiovascular comorbidity in early rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol., 2009, 23(1), 71-82.
9. Gasparyan, A.Y. Cardiovascular risk and inflammation: pathophysiological mechanisms, drug design, and targets. Curr. Pharm. Des., 2012, 18(11), 1447-1449.
10. Kitas, G.D.; Gabriel, S.E. Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. Ann. Rheum. Dis., 2011, 70(1), 8-14
11. Sarwar, N.; Gao, P.; Seshasai, S.R.; Gobin, R.; Kaptoge, S.; Di Angelantonio, E.; Ingelsson, E.; Lawlor, D.A.; Selvin, E.; Stampfer, M.; Stehouwer, C.D.; Lewington, S.; Pennells, L.; Thompson, A.; Sattar, N.; White, I.R.; Ray, K.K.; Danesh, J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet, 2010, 375(9733), 2215-2222.
12. Buse, J.B.; Ginsberg, H.N.; Bakris, G.L.; Clark, N.G.; Costa, F.; Eckel, R.; Fonseca, V.; Gerstein, H.C.; Grundy, S.; Nesto, R.W.; Pignone, M.P.; Plutzky, J.; Porte, D.; Redberg, R.; Stitzel, K.F.; Stone, N.J.; American Heart Association; American Diabetes Association. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation, 2007, 115(1), 114-126.
13. Nurmohamed, M.T.; Kitas, G. Cardiovascular risk in rheumatoid arthritis and diabetes: how does it compare and when does it start? Ann. Rheum. Dis., 2011, 70(6), 881-883.
14. Peters, M.J.; van Halm, V.P.; Voskuyl, A.E.; Smulders, Y.M.; Boers, M.; Lems, W.F.; Visser, M.; Stehouwer, C.D.; Dekker, J.M.; Nijpels, G.; Heine, R.; Dijkmans, B.A.; Nurmohamed, M.T. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study. Arthritis Rheum., 2009, 61(11), 1571-1579.
15. Kung, M.; Störk, S.; Angermann, C.E. Cardiovascular comorbidity in rheumatic disease. Does sex play a role? Herz, 2005, 30 (6), 512-521.
16. Norhammar, A, Schenck-Gustafsson, K. Type 2 diabetes and cardiovascular disease in women. Diabetologia, 2013, 56(1), 1-9.
17. Aslam, F.; Bandeali, S.J.; Khan, N.A.; Alam, M. Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res. (Hoboken)., 2013, 65(4), 534-543.
18. Mavrogeni, S.; Dimitroulas, T.; Sfikakis, P.P.; Kitas, G.D. Heart involvement in rheumatoid arthritis: Multimodality imaging and the emerging role of cardiac magnetic resonance. Semin. Arthritis Rheum., 2013, 43(3), 314-324.
19. John, H.; Kitas, G. Inflammatory arthritis as a novel risk factor for cardiovascular disease. Eur. J. Intern. Med., 2012, 23(7), 575-579.
20. van Halm, V.P. Peters, M.J.; Voskuyl, A.E.; Boers, M.; Lems, W.F.; Visser, M.; Stehouwer, C.D.; Spijkerman, A.M.; Dekker, J.M.; Nijpels, G.; Heine, R.J.; Bouter, L.M.; Smulders, Y.M.; Dijkmans, B.A.; Nurmohamed, M.T. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a crosssectional study, the CARRE Investigation. Ann. Rheum. Dis., 2009, 68(9), 1395-400.
21. Södergren, A.; Karp, K.; Boman, K.; Eriksson, C.; Lundström, E.; Smedby, T.; Söderlund, L.; Rantapää-Dahlqvist, S.; Wållberg- Jonsson, S. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Res. Ther., 2010, 12(4), R158.
22. Bartoloni, E.; Alunno, A.; Bistoni, O.; Gerli, R. How early is the atherosclerotic risk in rheumatoid arthritis? Autoimmun Rev., 2010, 9(10), 701-707.
23. Kremers, H.M.; Crowson, C.S.; Therneau, T.M.; Roger, V.L.; Gabriel, S.E. High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study. Arthritis Rheum., 2008, 58(8), 2268-2274.
24. Solomon, D.H.; Goodson, N.J.; Katz, J.N.; Weinblatt, M.E.; Avorn, J.; Setoguchi, S.; Canning, C.; Schneeweiss, S. Patterns of cardiovascular risk in rheumatoid arthritis. Ann. Rheum. Dis., 2006, 65(12), 1608-1612.
25. Maradit-Kremers, H.; Nicola, P.J.; Crowson, C.S.; Ballman, K.V.; Gabriel, S.E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum., 2005, 52(3), 722-732.
26. Libby, P. Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am. J. Med., 2008, 121(10 Suppl 1), S21-31.
27. Liao, K.P.; Solomon, D.H. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford), 2013, 52(1), 45-52.
28. Lazzerini, P.E.; Acampa, M.; Capecchi, P.L.; Hammoud, M.; Maffei, S.; Bisogno, S.; Barreca, C.; Galeazzi, M.; Laghi-Pasini, F. Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. Eur. J. Intern. Med., 2013, 24(4), 368-374.
29. Singh, H.V.; Shrivastava, A.K.; Raizada, A.; Singh, S.K.; Pandey, A.; Singh, N.; Yadav, D.; Sharma, H. Atherogenic lipid profile and high sensitive C-reactive protein in patients with rheumatoid arthritis. Clin. Biochem., 2013, 46(12), 1007-1012.
30. Ridker, P.M. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001, 103, 1813-1818.
31. Chighizola, C.; Schioppo, T.; Ingegnoli, F.; Meroni, P.L. Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis. Curr. Vasc. Pharmacol., 2012, 10, 639-646.
32. Choi, H.K.; Hernán, M.A.; Seeger, J.D.; Robins, J.M.; Wolfe, F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet, 2002, 359(9313), 1173-1177.
33. Solomon, A.; Woodiwiss, A.J.; Abdool-Carrim, A.T.; Stevens, B.A.; Norton, G.R.; Dessein, P.H. The carotid artery atherosclerosis burden and its relation to cardiovascular risk factors in black and white Africans with established rheumatoid arthritis: a cross-sectional study. J. Rheumatol., 2012, 39(9), 1798-806.
34. Hannawi, S.; Haluska, B.; Marwick, T.H.; Thomas, R. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther., 2007, 9, R116.
35. Stamatelopoulos, K.S.; Kitas, G.D. Papamichael, C.M.; Kyrkou, K.; Zampeli, E.; Fragiadaki, K.; Panoulas, V.F.; Mavrikakis, M.; Sfikakis, P.P. Subclinical peripheral arterial disease in rheumatoid arthritis. Atherosclerosis., 2010, 212(1), 305-309.
36. Gonzalez-Juanatey, C.; Llorca, J.; Martin, J.; Gonzalez-Gay, M.A. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin. Arthritis Rheum., 2009, 38(5), 366-371.
37. Sandoo, A.; Dimitroulas, T.; Veldhuijzen van Zanten, J.J.; Smith, J.P.; Metsios, G.S.; Nightingale, P.; Stavropoulos-Kalinoglou, A.; Kitas, G.D. Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis. Clin. Exp. Rheumatol., 2012, 30(3), 388-396.
38. Sandoo, A.; Veldhuijzen van Zanten, J.J.; Metsios, G.S.; Carroll, D.; Kitas, G.D. Vascular function and morphology in rheumatoid arthritis: a systematic review. Rheumatology (Oxford)., 2011, 50(11), 2125-2139.
39. Sandoo, A.; Protogerou, A.D.; Hodson, J.; Smith, J.P.; Zampeli, E.; Sfikakis, P.P.; Kitas, G.D. The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. Arthritis Res. Ther., 2012, 14(6), R258.
40. Sandoo, A.; Kitas, G.D. Current perspectives on the assessment of vascular function and morphology in rheumatoid arthritis. Int. J. Clin. Rheumatol., 2013, 8(1), 1-3.
41. Aubry, M.C.; Maradit-Kremers, H.; Reinalda, M.S.; Crowson, C.S.; Edwards, W.D.; Gabriel, S.E. Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis. J. Rheumatol., 2007, 34, 937-942.
42. Stamatelopoulos, K.S.; Kitas, G.D.; Papamichael, C.M.; Chryssohoou, E.; Kyrkou, K.; Georgiopoulos, G.; Protogerou, A.; Panoulas, V.F.; Sandoo, A.; Tentolouris, N.; Mavrikakis, M.; Sfikakis, P.P. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb. Vasc. Biol., 2009, 29(10), 1702-1708.
43. Douglas, K.M.; Pace, A.V.; Treharne, G.J.; Saratzis, A.; Nightingale, P.; Erb, N.; Banks, M.J.; Kitas, G.D. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann. Rheum. Dis., 2006, 65(3), 348-353.
44. Nicola, P.J.; Maradit-Kremers, H.; Roger, V.L.; Jacobsen, S.J.; Crowson, C.S.; Ballman, K.V.; Gabriel, S.E. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum., 2005, 52(2), 412-420.
45. Davis, J.M. 3rd.; Roger, V.L. Crowson, C.S. Kremers, H.M. Therneau, T.M. Gabriel, S.E. The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum., 2008, 58 (9), 2603-2611.
46. Abdul Muizz, A.M.; Mohd Shahrir, M.S.; Sazliyana, S.; Oteh, M.; Shamsul, A.S.; Hussein, H. A cross-sectional study of diastolic dysfunction in rheumatoid arthritis and its association with disease activity. Int. J. Rheum. Dis., 2011, 14(1), 18-30.
47. Wislowska, M.; Jaszczyk, B.; Kochmański, M.; Sypuła, S.; Sztechman, M. Diastolic heart function in RA patients. Rheumatol. Int., 2008, 28(6), 513-519.
48. Gonzalez-Juanatey, C.; Testa, A.; Garcia-Castelo, A.; Garcia- Porrua, C.; Llorca, J.; Ollier, W.E.; Gonzalez-Gay, M.A. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin. Arthritis Rheum., 2004, 33 (4), 231-238.
49. Myasoedova, E.; Davis, J.M. 3rd.; Crowson, C.S.; Roger, V.L.; Karon, B.L.; Borgeson, D.D.; Therneau, T.M.; Matteson, E.L.; Rodeheffer, R.J.; Gabriel, S.E. Brief report: rheumatoid arthritis is associated with left ventricular concentric remodeling: results of a population-based cross-sectional study. Arthritis Rheum., 2013, 65(7), 1713-1718.
50. Corrao, S.; Calvo, L.; Argano, C.; Licata, G. The heart in rheumatoid arthritis: contrasting or misleading data from clinical research? Comment on the article by Giles et al. Arthritis Rheum., 2010, 62 (12), 3833-3834; author reply 3834-3835.
51. Puntmann, V.O.; Taylor, P.C.; Barr, A.; Schnackenburg, B.; Jahnke, C.; Paetsch, I. Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study. Rheumatology (Oxford), 2010, 49(3), 528-535.
52. Myasoedova, E.; Crowson, C.S.; Nicola, P.J.; Maradit-Kremers, H.; Davis, J.M. 3rd.; Roger, V.L.; Therneau, T.M.; Gabriel, S.E. The influence of rheumatoid arthritis disease characteristics on heart failure. J. Rheumatol., 2011, 38(8), 1601-1606.
53. Giles, J.T.; Fert-Bober, J.; Park, J.K.; Bingham, C.O. 3rd.; Andrade, F.; Fox-Talbot, K.; Pappas, D.; Rosen, A.; van Eyk, J.; Bathon, J.M.; Halushka, M.K. Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res. Ther., 2012, 14(1), R39.
54. Davis, J.M. 3rd.; Knutson, K.L.; Strausbauch, M.A.; Crowson, C.S.; Therneau, T.M.; Wettstein, P.J.; Roger, V.L.; Matteson, E.L.; Gabriel, S.E. A signature of aberrant immune responsiveness identifies myocardial dysfunction in rheumatoid arthritis. Arthritis Rheum., 2011, 63(6), 1497-1506.
55. Mavrogeni, S.; Karabela, G.; Stavropoulos, E.; Gialafos, E.; Sfendouraki, E.; Kyrou, L.; Kolovou, G. Imaging patterns of heart failure in rheumatoid arthritis evaluated by cardiovascular magnetic resonance. Int. J. Cardiol., 2013, 168(4), 4333-4335.
56. Jurik, A.G.; Graudal, H. Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol. Int., 1986, 6(1), 37-42.
57. Voskuyl, A.E. The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford), 2006, 45 (Suppl 4), iv 4-7.
58. Hara, K.S.; Ballard, D.J.; Ilstrup, D.M.; Connolly, D.C.; Vollertsen, R.S. Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore), 1990, 69(2), 81-91.
59. Levy, P.Y.; Corey, R.; Berger, P.; Habib, G.; Bonnet, J.L.; Levy, S.; Messana, T.; Djiane, P.; Frances, Y.; Botta, C.; DeMicco, P.; Dumon, H.; Mundler, O.; Chomel, J.J.; Raoult, D. Etiologic diagnosis of 204 pericardial effusions. Medicine, 2003, 82, 385-391.
60. Guedes, C.; Bianchi-Fior, P.; Cormier, B.; Barthelemy, B.; Rat, A.C.; Boissier, M.C. Cardiac manifestations of rheumatoid arthritis: A case-control transesophageal echocardiography study in 30 patients. Arthritis Rheum., 2001, 45, 129-135.
61. Chand, E.M.; Freant, L.J.; Rubin, J.W. Aortic valve rheumatoid nodules producing clinical aortic regurgitation and a review of the literature. Cardiovasc. Pathol., 1999, 8, 333-338.
62. Giles, J.T.; Fernandes, V.; Lima, J.A.; Bathon, J.M. Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res. Ther., 2005, 7(5), 195-207.
63. Mavrogeni, S.; Dimitroulas, T.; Kitas, G.D. Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun. Rev., 2012, 12(2), 305-312.
64. Pappas, D.A.; Taube, J.M.; Bathon, J.M.; Giles, J.T. A 73-year-old woman with rheumatoid arthritis and shortness of breath. Arthritis Rheum., 2008, 59(6), 892-899.
65. Mavrogeni, S.; Bratis, K.; Sfendouraki, E.; Papadopoulou, E.; Kolovou, G. Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance. Inflamm. Allergy Drug Targets, 2013, 12(3), 206-211.
66. Bély, M.; Apáthy, A. Vasculitis in rheumatoid arthritis. Orv. Hetil., 1996, 137(29),1571-1578.
67. van Albada-Kuipers, G.A.; Bruijn, J.A.; Westedt, M.L.; Breedveld, F.C.; Eulderink, F. Coronary arteritis complicating rheumatoid arthritis. Ann. Rheum. Dis., 1986, 45(11), 963-965.
68. Slack, J.D.; Waller, B. Acute congestive heart failure due to the arteritis of rheumatoid arthritis: early diagnosis by endomyocardial biopsy: a case report. Angiology, 1986, 37(6), 477-482.
69. Cunnane, G.; Whitehead, A.S. Amyloid precursors and amyloidosis in rheumatoid arthritis. Bailliere's Clin. Rheumatol., 1999, 13, 615-628.
70. Kuroda, T.; Tanabe, N.; Harada, T.; Murakami, S.; Hasegawa, H.; Sakatsume, M.; Nakano, M.; Gejyo, F. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis. Clin. Rheumatol., 2005, 3, 1-8.
71. Pieringer, H.; Pichler, M.; Pohanka, E.; Hoppe, U.C. Will Antirheumatic Treatment Improve Cardiovascular Outcomes in Patients with Rheumatoid Arthritis? Curr. Pharm. Des., 2014, 20(4), 486-495.
72. Indhardsen, J.; Ahlehoff, O.; Gislason, G.H.; Madsen, O.R.; Olesen, J.B.; Torp-Pedersen, C.; Hansen, P.R. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann. Rheum. Dis., 2011, 70(6), 929-934.
73. Banks, M.J.; Flint, E.J.; Bacon, P.A.; Kitas, G. Rheumatoid arthritis is an independent risk factor for ischaemic heart disease. Arthritis Rheum., 2000, 43, S385.
74. Wislowska, M.; Sypula, S.; Kowalick, I. Echocardiographic findings, 24 hour electrocardiographic holter monitoring in patients with rheumatoid arthritis according to Steinbocker's criteria, functional index, value of Waaler-Rose titre and duration of disease. Clin. Rheumatol., 1998, 17, 369-377.
75. Maradit-Kremers, H.; Crowson, C.S.; Nicola, P.J.; Ballman, K.V.; Roger, V.L.; Jacobsen, S.J.; Gabriel, S.E. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis. Arthritis Rheum., 2005, 52, 402-411.
76. Cohn, P.F.; Fox, K.M.; Daly, C. Silent myocardial ischemia. Circulation, 2003, 108(10), 1263-1277.
77. Li, J.J. Silent myocardial ischemia may be related to inflammatory response. Med. Hypotheses, 2004, 62(2), 252-256.
78. Sheifer, S.E.; Manolio, T.A.; Gersh, B.J. Unrecognized myocardial infarction. Ann. Intern. Med., 2001, 135(9), 801-811.
79. Protogerou, A.; Zampeli, E.; Tentolouris, N.; Makrilakis, K.; Kitas, G.; Sfikakis, P.P. Subclinical femoral atheromatosis in rheumatoid arthritis: comparable prevalence to diabetes mellitus in a casecontrol study. Ann. Rheum. Dis., 2012, 71(9), 1534-1536.
80. Hotamisligil, G.S.; Arner, P.; Caro, J.F.; Atkinson, R.L.; Spiegelman, B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest., 1995, 95, 2409-2415.
81. Gonzalez-Gay, M.A.; De Matias, J.M.; Gonzalez-Juanatey, C.; Garcia-Porrua, C.; Sanchez-Andrade, A.; Martin, J.; Llorca, J. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin. Exp. Rheumatol., 2006, 24(1), 83-86.
82. van Eijk, I.C.; Peters, M.J.; Nurmohamed, M.T.; van Deutekom, A.W.; Dijkmans, B.A.; Simsek, S. Decrease of fructosamine levels during treatment with adalimumab in patients with both diabetes and rheumatoid arthritis. Eur. J. Endocrinol., 2007, 156 (3), 291-293.
83. Aneja, A.; Tang, W.H.; Bansilal, S.; Garcia, M.J.; Farkouh, M.E. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am. J. Med., 2008, 121, 748-757.
84. Laakso M. Heart in diabetes: a microvascular disease. Diabetes Care, 2011, 34 (Suppl 2), S145-S149.
85. Shivu, G.N.; Abozguia, K.; Phan, T.T.; Ahmed, I.; Weaver, R.; Narendran, P.; Stevens, M.; Frenneaux, M. Increased left ventricular torsion in uncomplicated type 1 diabetic patients: the role of coronary microvascular function. Diabetes Care, 2009, 32(9), 1710-1712.
86. Mavrogeni, S.; Bratis, K.; Gavra, P.; Fousteris, E.; Markussis, V.; Kolovou, G.; van Wijk, K.; Hautemann, D.; Reiber, J.H.; Melidonis, A. Stress cardiac magnetic resonance reveals myocardial perfusion impairment in asymptomatic diabetes mellitus type I, missed by the routine non-invasive evaluation. Int. J. Cardiol., 2013, 167(6), e167-e169.
87. Raza, K.; Banks, M.; Kitas, G.D. Reversing myocardial microvascular disease in a patient with rheumatoid arthritis. J. Rheumatol., 2005, 32(4), 754-756.
88. Emerging Risk Factors Collaboration; Seshasai, S.R.; Kaptoge, S.; Thompson, A.; Di Angelantonio, E.; Gao, P.; Sarwar, N.; Whincup, P.H.; Mukamal, K.J.; Gillum, R.F.; Holme, I.; Njølstad, I.; Fletcher, A.; Nilsson, P.; Lewington, S.; Collins, R.; Gudnason, V.; Thompson, S.G.; Sattar, N.; Selvin, E.; Hu, F.B.; Danesh, J. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med., 2011, 364(9), 829-841.
89. Peters, M.J.; Symmons, D.P.; McCarey, D.; Dijkmans, B.A.; Nicola, P.; Kvien, T.K.; McInnes, I.B.; Haentzschel, H.; Gonzalez- Gay, M.A.; Provan, S.; Semb, A.; Sidiropoulos, P.; Kitas, G.; Smulders, Y.M.; Soubrier, M.; Szekanecz, Z.; Sattar, N.; Nurmohamed, M.T. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann. Rheum. Dis., 2010, 69(2), 325-3231.
90. Pennell, D.J.; Udelson, J.E.; Arai, A.E.; Bozkurt, B.; Cohen, A.R.; Galanello, R.; Hoffman, T.M.; Kiernan, M.S.; Lerakis, S.; Piga, A.; Porter, J.B.; Walker, J.M.; Wood, J. American Heart Association Committee on Heart Failure and Transplantation of the Council on Clinical Cardiology and Council on Cardiovascular Radiology and Imaging. Cardiovascular Function and Treatment in β-Thalassemia Major: A Consensus Statement from the American Heart Association. Circulation, 2013, 128(3), 281-308.
91. Mavrogeni, S.; Bratis, K.; Papachristou, P.; Giannakopoulou, E.; Karanasios, E.; Kolovou, G.; van Wijk, K.; Hautemann, D.; Reiber, J.H.; Papadopoulos, G. Stress perfusion-fibrosis cardiac magnetic resonance detects early heart involvement in young asymptomatic, homozygous familial hyperlipidemia with normal routine noninvasive evaluation. Int. J. Cardiol., 2013, 168(4), 4570-4572.
92. Lightfoot, J.C.; D'Agostino, R.B. Jr.; Hamilton, C.A.; Jordan, J.; Torti, F.M.; Kock, N.D.; Jordan, J.; Workman, S.; Hundley, W.G. Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model. Circ. Cardiovasc. Imaging, 2010, 3(5), 550-558.
93. Friedrich, M.G.; Sechtem, U.; Schulz-Menger, J.; Holmvang, G.; Alakija, P.; Cooper, L.T.; White, J.A.; Abdel-Aty, H.; Gutberlet, M.; Prasad, S.; Aletras, A.; Laissy, J.P.; Paterson, I.; Filipchuk, N.G.; Kumar, A.; Pauschinger, M.; Liu, P.International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. JACC, 2009, 53, 1475-1487.
94. Mavrogeni, S.; Spargias, K.; Markussis, V.; Kolovou, G.; Demerouti, E.; Papadopoulou, E.; Stavridis, G.; Kaklamanis, L.; Douskou, M.; Constantoulakis, P.; Cokkinos, D.V. Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm. Allergy Drug Targets, 2009, 8(5), 390-397.
95. Gerber, B.L.; Garot, J.; Bluemke, D.A.; Wu, K.C.; Lima, J.A. Accuracy of contrast enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation, 2002, 106, 1083-1089.
96. Kim, R.J.; Fieno, D.S.; Parrish, T.B.; Harris, K.; Chen, E.L.; Simonetti, O.; Bundy, J.; Finn, J.P.; Klocke, F.J.; Judd, R.M. Relationship of mri delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation, 1999, 100, 1992-2002.
97. Kim, R.J.; Wu, E.; Rafael, A.; Chen, E.L.; Parker, M.A.; Simonetti, O.; Klocke, F.J.; Bonow, R.O.; Judd, R.M. The use of contrastenhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N. Engl. J. Med., 2000, 343, 1445-1453.
98. White, J.A.; Fine, N.M.; Gula, L.; Yee, R.; Skanes, A.; Klein, G.; Leong-Sit, P.; Warren, H.; Thompson, T.; Drangova, M.; Krahn, A. Utility of cardiovascular magnetic resonance in identifying substrate for malignant ventricular arrhythmias. Circ. Cardiovasc. Imaging, 2012, 5(1), 12-20.
99. Krahn, A.D.; Healey, J.S.; Chauhan, V.; Birnie, D.H.; Simpson, C.S.; Champagne, J.; Gardner, M.; Sanatani, S.; Exner, D.V.; Klein, G.J.; Yee, R.; Skanes, A.C.; Gula, L.J.; Gollob, M.H. Systematic assessment of patients with unexplained cardiac arrest: cardiac arrest survivors with preserved ejection fraction registry (casper). Circulation, 2009, 120, 278-285.
100. Bello, D.; Fieno, D.S.; Kim, R.J.; Pereles, F.S.; Passman, R.; Song, G.; Kadish, A.H.; Goldberger, J.J. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J. Am. Coll. Cardiol., 2005, 45, 1104-1108.
101. White, J.A.; Patel, M.R. The role of cardiovascular MRI in heart failure and the cardiomyopathies. Cardiol. Clin., 2007, 25, 71-95.
102. Mavrogeni, S.; Karabela, G.; Stavropoulos, E.; Gialafos, E.; Sfendouraki, E.; Kyrou, L.; Kolovou, G. Imaging patterns of heart failure in rheumatoid arthritis evaluated by cardiovascular magnetic resonance. Int. J. Cardiol., 2013, 168(4), 4333-4335.
103. Mavrogeni, S.; Vassilopoulos, D. Is there a place for cardiovascular magnetic resonance imaging in the evaluation of cardiovascular involvement in rheumatic diseases? Semin. Arthritis Rheum., 2011, 41(3), 488-496.
104. Vinit, J.; Bielefeld, P.; Muller, G.; Pfitzenmeyer, P.; Bonniaud, P.; Lorcerie, B.; Besancenot, J.F. Heart involvement in Churg-Strauss syndrome: retrospective study in French Burgundy population in past 10 years. Eur. J. Intern. Med., 2010, 21, 341-346.
105. Wassmuth, R.; Gobel, U.; Natusch, A.; Schneider, W.; Kettritz, R.; Dietz, R.; Luft, F.C.; Schulz-Menger, J. Cardiovascular magnetic resonance imaging detects cardiac involvement in Churg-Strauss syndrome. J. Card. Fail, 2008, 14, 856-860.
106. Raman, S.V.; Aneja, A.; Jarjour, W.N. CMR in inflammatory vasculitis. J. Cardiovasc. Magn. Reson., 2012, 14, 82
107. Chun, W.; Grist, T.M.; Kamp, T.J.; Warner, T.F.; Christian, T.F. Images in cardiovascular medicine. Infiltrative eosinophilic myocarditis diagnosed and localized by cardiac magnetic resonance imaging. Circulation, 2004, 110, e19.
108. Schwitter, J. Myocardial perfusion imaging by cardiac magnetic resonance. J. Nucl. Cardiol., 2006, 13, 841-854.
109. Schwitter, J.; Nanz, D.; Kneifel, S.; Bertschinger, K.; Buchi, M.; Knusel, P.R.; Marincek, B.; Luscher, T.F.; von Schulthess, G.K. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation, 2001, 103, 2230-2235.
110. Plein, S.; Ryf, S.; Schwitter, J.; Radjenovic, A.; Boesiger, P.; Kozerke, S. Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn. Reson. Med., 2007, 58, 777-785.
111. Gebker, R.; Jahnke, C.; Paetsch, I.; Kelle, S.; Schnackenburg, B.; Fleck, E.; Nagel, E. Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease. Radiology, 2008, 247, 57-63.
112. Greenwood, J.P.; Maredia, N.; Younger, J.F.; Brown, J.M.; Nixon, J.; Everett, C.C.; Bijsterveld, P.; Ridgway, J.P.; Radjenovic, A.; Dickinson, C.J.; Ball, S.G.; Plein, S. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet, 2012, 379, 453-460.
113. Gargiulo, P.; Dellegrottaglie, S.; Bruzzese, D.; Savarese, G.; Scala, O.; Ruggiero, D.; D'Amore, C.; Paolillo, S.; Agostoni, P.; Bossone, E.; Soricelli, A.; Cuocolo, A.; Trimarco, B.; Filardi, P.P. The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a metaanalysis. Circ. Cardiovasc. Imaging, 2013, 6(4), 574-582.
114. Emerging Risk Factors Collaboration; Seshasai, S.R.; Kaptoge, S.; Thompson, A.; Di Angelantonio, E.; Gao, P.; Sarwar, N.; Whincup, P.H.; Mukamal, K.J.; Gillum, R.F.; Holme, I.; Njølstad, I.; Fletcher, A.; Nilsson, P.; Lewington, S.; Collins, R.; Gudnason, V.; Thompson, S.G.; Sattar, N.; Selvin, E.; Hu, F.B.; Danesh, J. Comparison of magnetic resonance real-time imaging of LV function with conventional magnetic resonance imaging and echocardiography. Am. J. Cardiol., 2001, 87, 95-99.
115. Redline, S.; Yenokyan, G.; Gottlieb, D.J.; Shahar, E.; O'Connor, G.T.; Resnick, H.E.; Diener-West, M.; Sanders, M.H.; Wolf, P.A.; Geraghty, E.M.; Ali, T.; Lebowitz, M.; Punjabi, N.M. Magnetic resonance imaging compared to echo/phy to assess LV MASS in the hypertensive patient. Am. J. Hypertension., 1995, 8, 221-226.
116. Giles, J.T.; Malayeri, A.A.; Fernandes, V.; Post, W.; Blumenthal, R.S.; Bluemke, D.; Vogel-Claussen, J.; Szklo, M.; Petri, M.; Gelber, A.C.; Brumback, L.; Lima, J.; Bathon, J.M. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum., 2010, 6, 940-951.
117. Chiribiri, A.; Botnar, R.M.; Nagel, E. Magnetic resonance coronary angiography: where are we today? Curr. Cardiol. Rep., 2013, 15(2), 328.
118. Mavrogeni, S.; Manoussakis, M.N.; Karagiorga, T.C.; Douskou, M.; Panagiotakos, D.; Bournia, V.; Cokkinos, D.V.; Moutsopoulos, H.M. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum., 2009, 61(8), 1121-1129.
119. Terashima, M.; Nguyen, P.K.; Rubin, G.D.; Meyer, C.H.; Shimakawa, A.; Nishimura, D.G.; Ehara, S.; Iribarren, C.; Courtney, B.K.; Go, A.S.; Hlatky, M.A.; Fortmann, S.P.; McConnell, M.V. Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J. Cardiovasc. Magn. Reson., 2010, 12, 75.
120. Kim, W.Y.; Astrup, A.S.; Stuber, M.; Tarnow, L.; Falk, E.; Botnar, R.M.; Simonsen, C.; Pietraszek, L.; Hansen, P.R.; Manning, W.J.; Andersen, N.T.; Parving, H.H. Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation, 2007, 115(2), 228-235.
121. Bourque, J.M.; Schietinger, B.J.; Kennedy, J.L.; Pearce, E.A.; Christopher, J.M.; Taylor, A.M.; McNamara, C.A.; Kramer, C.M. Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis. Am. J. Cardiol., 2012, 110(1), 50-56.
122. Bourantas, C.V.; Loh, H.P.; Sherwi, N.; Tweddel, A.C.; de Silva, R.; Lukaschuk, E.I.; Nicholson, A.; Rigby, A.S.; Thackray, S.D.; Ettles, D.F.; Nikitin, N.P.; Clark, A.L.; Cleland, J.G. Atherosclerotic disease of the abdominal aorta and its branches: prognostic implications in patients with heart failure.Heart Fail Rev., 2012, 17(2), 229-239.
123. Weckbach, S.; Findeisen, H.M.; Schoenberg, S.O.; Kramer, H.; Stark, R.; Clevert, D.A.; Reiser, M.F.; Parhofer, K.G. Systemic cardiovascular complications in patients with long-standing diabetes mellitus: comprehensive assessment with whole-body magnetic resonance imaging/magnetic resonance angiography. Invest. Radiol., 2009, 44(4), 242-250